Denied ‘life-extending opportunities’: Black patients are being left out of clinical trials amid wave of new cancer therapies
African-Americans are widely underrepresented in clinical trials for cancer drugs, even when the type of cancer disproportionately affects them.
No hay comentarios:
Publicar un comentario